- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Pain Therapeutics Inc
+ Add to WatchlistPTIE:US
2.8050 USD 0.0550 1.92%As of 14:56:52 ET on 05/24/2013.
Snapshot for Pain Therapeutics Inc (PTIE)
| Open: | 2.8600 | Day's Range: | 2.7500 - 2.8600 | Volume: | 134,186 |
|---|---|---|---|---|---|
| Previous Close: | 2.8600 | 52wk Range: | 2.0576 - 5.5700 | 1-Yr Rtn: | -6.20% |
Key Statistics for PTIE
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.0800 |
| Est. EPS (USD) (12/2013) | -0.0650 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 126.93 |
| Shares Outstanding (M) | 45.33 |
| 30 Day Average Volume | 580,059 |
| Price/Book (mrq) | 9.4653 |
| Price/Sale (ttm) | 12.7000 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | 0.7500 |
| Last Dividend | 12/13/2012 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PTIE
Company Profile & Key Executives for PTIE
Pain Therapeutics, Inc. develops drugs using it proprietary technology. The Company develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. Pain Therapeutics has products in clinical trials.
| Remi BarbierChairman/President/CEO | Nadav FriedmannCOO/Chief Medical Officer |
| Grant L SchoenhardChief Scientific Officer | Peter S RoddyVP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PTIE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page